These findings, for the first time, indicated that α-Syn seeding activity could be a consistent pathological feature of PRKN-linked PD, supporting that α-Syn seeding activity monitored by NEVs-dependent SAA protocol can be a promising biomarker for PD [40]. This evidence concerns the gene PRKN and Parkinson disease.